Additional Information
Book Details
Abstract
With the objective of limiting the individual family size to just one or two children, most women spend the larger part of their reproductive years attempting to avoid an unwanted or unplanned pregnancy. Effective fertility control is important in a woman’s life to give her the choices of planning her family and to empower her to accomplish her goals in life besides, those of mere childbearing and childrearing. As with many other preventative medical interventions, the efficacy of contraceptive measures cannot be directly assessed; only failures can be quantified. The Pearl index is a statistical tool in this context, for measuring the effectiveness of the fertility control method and estimation of the number of unintended pregnancies per 100 woman-years of exposure. It is also used to compare the birth control methods with a lower Pearl index denoting a lower chance of getting unintentionally pregnant. Fertility Control has come up with comparative study of different controlling techniques, along with the clinical experiences of its eminent authors.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Front Cover | ||
Front Matter | ia | ||
Elsevier Clinical Advisory Board:Obstetrics & Gynecology | ic | ||
Copyright | ie | ||
About the Authors | if | ||
Contents | ih | ||
ECAB Clinical Update InformationFertility Control | i | ||
Introduction | 1 | ||
Hormonal Contraception: Contraceptive Options, Oral Contraception, ClinicalConcerns, Myths, Misinformation | 5a | ||
ABSTRACT | 5a | ||
KEYWORDS | 5b | ||
HISTORY | 6 | ||
CONTRACEPTIVE EFFICACY | 8 | ||
CONTRACEPTIVE OPTIONS | 8 | ||
Oral Contraception | 9 | ||
Introduction | 9 | ||
Formulations | 10 | ||
Mechanism of Action | 11 | ||
Side Effects | 11 | ||
Evaluation of Abnormal Uterine Bleeding in Women Using Hormonal Contraception | 11 | ||
Contraindications | 12 | ||
Absolute | 12 | ||
Relative contraindications | 13 | ||
Noncontraceptive Benefits of Oral Contraception | 13 | ||
Effects of Oral Contraception on Laboratory Parameters | 14 | ||
Major Clinical Concerns | 15 | ||
Cancer risks | 15 | ||
Cardiovascular disease risks | 16 | ||
Subarachnoid Hemorrhage and stroke | 16 | ||
Blood pressure | 16 | ||
Association of OCPs and common medical disorders | 16 | ||
Drug Interaction and Oral Contraception | 17 | ||
Decision for Prescribing the Pill | 18 | ||
Selection of the OCP | 18 | ||
How to Start the OCPs | 18 | ||
Follow-up | 19 | ||
Warning Signs | 19 | ||
Prescribing Issues | 20 | ||
Myths and Misinformation | 20 | ||
Planning a Future Pregnancy | 21 | ||
Special Applications | 21 | ||
Extended-Cycle Combined Hormonal Contraception | 21 | ||
SUMMARY | 24 | ||
25 | |||
Case Studies Hormonal Contraception: Contraceptive Options, Oral Contraception, Clinical Concerns, Myths, Misinformation | 28 | ||
CASE STUDY I | 28 | ||
History | 28 | ||
Discussion | 29 | ||
CASE STUDY II | 29 | ||
History | 29 | ||
Evaluation | 29 | ||
General Examination | 29 | ||
Systemic Examination | 30 | ||
Gynecological Examination | 30 | ||
Investigations | 30 | ||
Clinical Diagnosis | 30 | ||
Management/Treatment Given | 31 | ||
Discussion | 31 | ||
CASE STUDY III | 31 | ||
History | 31 | ||
Personal, Medical, Surgical, and Family History | 31 | ||
Menstrual History | 32 | ||
Obstetric History | 32 | ||
Evaluation | 32 | ||
Physical Examination | 32 | ||
Investigations | 32 | ||
Clinical Diagnosis: Dysfunctional Uterine Bleeding | 33 | ||
Treatment Options and Management Plans | 33 | ||
Discussion | 33 | ||
Take Home Message | 34 | ||
Injectable and Surgical Contraception | 35a | ||
ABSTRACT | 35a | ||
KEYWORDS | 35a | ||
INJECTABLE CONTRACEPTIVES | 35a | ||
Mechanism of Action | 36 | ||
Advantages | 36 | ||
Disadvantages | 36 | ||
CONTRACEPTIVE (STEROID) IMPLANTS | 37 | ||
Introduction | 37 | ||
Advantages | 40 | ||
Disadvantages | 41 | ||
Future Implants | 41 | ||
Biodegradable Implants | 42 | ||
INTRAUTERINE CONTRACEPTIVE DEVICES | 43 | ||
History | 43 | ||
Types of Intrauterine Contraceptive Devices | 44 | ||
Mechanism of Action | 45 | ||
Advantage | 45 | ||
Noncontraceptive health benefits of the levonorgestrel-releasing IUD | 45 | ||
Disadvantage | 46 | ||
Levonorgesteral Intrauterine System (LNG-IUS) or Hormone IUD | 48 | ||
VOLUNTARY STERILIZATION | 49 | ||
Female Sterilization | 50 | ||
Advantages | 50 | ||
Disadvantages | 51 | ||
Male Sterilization | 51 | ||
Advantages | 51 | ||
Disadvantages | 52 | ||
Case Studies Injectable and Surgical Contraception | 55 | ||
CASE STUDY I: INJECTABLE DMPA ADVISED | 55 | ||
History | 55 | ||
Management | 55 | ||
CASE STUDY II: INSERTION OF CU-T 200 | 55 | ||
Contraception in Special Cases | 59a | ||
ABSTRACT | 59a | ||
KEYWORDS | 59a | ||
EMERGENCY CONTRACEPTION | 61 | ||
Indications for Emergency Contraception | 61 | ||
Mechanism of Action | 63 | ||
LNG: The Dedicated Method of Choice | 63 | ||
Dosage Schedule and Time Frame | 63 | ||
Limitations | 64 | ||
Safety of ECP | 64 | ||
Side Effects | 64 | ||
GLOBAL UPDATE | 64 | ||
INDIAN UPDATE | 66 | ||
POSTABORTION CONTRACEPTION | 67 | ||
Concurrent Contraception | 68 | ||
Conclusion | 71 | ||
POSTPARTUM CONTRACEPTION | 71 | ||
Available Options | 71 | ||
CONTRACEPTIVE AWARENESS AND USAGE | 75 | ||
INDIAN UPDATE | 75 | ||
THE UNMET NEED OF CONTRACEPTION | 76 | ||
Definition of Unmet Need | 77 | ||
Measuring \"Unmet Need | 78 | ||
Reasons for \"Unmet Need | 80 | ||
Knowledge of Contraceptive Methods | 81 | ||
Socioeconomic Differentials | 82 | ||
Health Concerns | 83 | ||
Perceived Risk of Pregnancy and Partner Opposition | 83 | ||
IMPACT OF UNMET NEED ON FERTILITY | 84 | ||
STRATEGIES TO REDUCE UNMET NEED | 84 | ||
GLOBAL ISSUE | 86 | ||
INDIAN SCENARIO | 87 | ||
POLICIES AND PROGRAMS | 88 | ||
SUMMARY | 89 | ||
CASE STUDY I | 91 | ||
History | 91 | ||
Spontaneous conception | 91 | ||
History of Present Pregnancy | 91 | ||
Menstrual History | 91 | ||
On Examination | 92 | ||
Advise Postpartum | 92 | ||
CASE STUDY II | 93 | ||
History | 93 | ||
Menstrual History | 93 | ||
Obstetric History | 93 | ||
Family History | 93 | ||
Postpartum | 94 | ||
CASE STUDY III | 94 | ||
History | 94 | ||
Menstrual History | 94 | ||
Obstetric History | 94 | ||
On Examination | 95 | ||
Diagnosis | 95 | ||
CASE STUDY IV | 95 | ||
History | 95 | ||
In Labor | 96 | ||
History of Present Pregnancy | 96 | ||
Past History | 96 | ||
On Examination | 96 | ||
Advice Postpartum | 97 | ||
Summary | 100 | ||
HORMONAL ORAL CONTRACEPTIVES | 101 | ||
Oral Contraceptive Pills | 101 | ||
Hormonal Injectable Contraceptives | 101 | ||
Hormonal Implants | 101 | ||
Hormonal Patches | 102 | ||
Hormonal Emergency Contraceptives | 102 | ||
NONHORMONAL CONTRACEPTIVES | 102 | ||
Condom | 102 | ||
Diaphragm | 102 | ||
Copper IUDs | 102 | ||
Cycle-based Fertility Awareness | 103 | ||
PERMANENT METHODS | 103 | ||
Male Sterilization | 103 | ||
Female Sterilization | 103 | ||
CONTRACEPTION IN SPECIAL CASES | 103 | ||
Postabortion Contraception | 103 | ||
Postpartum Contraception | 104 | ||
Emergency Contraception | 104 | ||
THE FUTURE | 104 | ||
ECAB ClinicalUpdate: Obstetrics &GynecologyForthcoming Books | 106 |